The first COVAX shipment of 348,000 doses of AstraZeneca’s Covishield vaccine arrived safely in Kathmandu, Nepal’s capital, before being distributed to provinces and municipalities throughout the world.
The vaccines, which were manufactured by the Serum Institute of India (SII), as well as 350,000 syringes and 3,500 vaccine safety boxes, arrived in Kathmandu on March 7, making Nepal one of the first countries in Asia to receive COVID-19 vaccines from the COVAX Facility, which will aid the government’s efforts to vaccinate some of Nepal’s most vulnerable population.
Vaccines funded by COVAX are an important part of the Government of Nepal’s National Deployment and Vaccination Plan (NDVP), which aims to vaccinate approximately 22 million people, including refugees, migrant returnees, and other migrant populations. Nepal was able to start the vaccination campaign thanks to the generous contribution of the Indian government, and 429,705 people have been vaccinated to date. Members of the WHO Nepal team, such as driver Laxmi Thapa Magar, are critical in reaching vulnerable people in Nepal’s remote provinces.
WHO
Award-Winning Burmese Journalist Shin Daewe Released from Prison
UN Security Council Meets on Situation in Sudan and South Sudan
Mexican’s Zoo’s Star attraction Yuji, Abandoned Newborn Monkey
Sinhala Hound
UN Permanent Representative of Israel Briefs Press
Web Cache Poisoning
Michigan Delivery Driver Shot Missing Dog, Found Alive After Bullet Bounced Off Skull
